New decision aid empowers thyroid cancer patients to choose their care path
NCT ID NCT03892993
First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 2 times
Summary
This study creates and tests a decision aid for people with medullary thyroid cancer and their caregivers. The tool helps them discuss with their doctors whether to start or stop drugs, join clinical trials, or continue active monitoring. About 120 participants, including patients, caregivers, and providers, will help refine the aid to ensure it presents options clearly and fairly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEDULLARY THYROID CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Massive database study probes link between popular diabetes drugs and rare thyroid cancer
- New PET tracer could spot cancers that standard scans overlook
- New imaging agent could improve detection of rare cancers
- Could a smaller surgery spare medullary thyroid cancer patients from lifelong pills?
- New hope for advanced thyroid cancer: drug shows tumor-shrinking promise
- New radioactive therapy targets hard-to-treat thyroid cancer